Search Results 21-30 of 16469 for ������������KA���:ZA31���24������ ���������������������������������

  1. Hyperparathyroidism - Diagnosis & treatment - Mayo Clinic

    Additional tests · Bone mineral density test. This test is done to see if you have developed osteoporosis. · Urine test. A 24-hour collection of urine can provide ...

  2. Centered Psychotherapy for Caregivers of Patients With Advanced Cancer - Mayo Clinic

    Jacksonville, Florida: 24-004250. NCT ID: NCT06630351. Sponsor Protocol Number: 24-004250. About this study. The purpose of this study to determine ...

  3. A Multicenter Open Label Trial Using Ambrisentan in Patients with Porto-pulmonary Hypertension - Mayo Clinic

    In addition, the Investigator will assess each subject for safety and efficacy at Week 4, Week 12, and Week 24. Following Week 24, subjects will be assessed for ...

  4. Clinical Trials

    Blood is inherently well suited for detection of cancer biomarkers as it contains circulating tumor cells and tumor cell-free DNA (cfDNA) that have been “shed” ...

  5. Publications - Prathibha Varkey, M.B.B.S., M.B.A. - Mayo Clinic

    North F, Richards DD, Bremseth KA, Lee MR, Cox DL, Varkey P, Stroebel RJ. ... Epub 2012 Feb 24. View PubMed; Varkey P, Jatoi A ... 2009 May-Jun; 24(3):214-21.

  6. Intravenous Ketamine for Treatment-Resistant Depression (G2K) - Mayo Clinic

    Rochester, Minnesota: 24-005249. NCT ID ... 24-hr post-infusion change in depression (MADRS) ... Zachary; Lapidus KA. Kyle A B; Kang G. Guoxin ...

  7. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  8. Family planning: Get the facts about pregnancy spacing - Mayo Clinic

    For most people, it's best to wait 18 to 24 months but less than five years after a live birth before getting pregnant again. This lowers the risk of health ...

  9. Predicting the Safety and Effectiveness of Inferior Vena Cava Filters - Mayo Clinic

    All treated subjects will be evaluated at procedure, 3-months, 6-months (phone), 12-months, 18-months (phone), and 24-months post-procedure. The primary ...

  10. Assay Utility for the Diagnosis of Bladder Cancer in Patients with Atypical Cytology or Equivocal Cystoscopy - Mayo Clinic

    Rochester, Minnesota: 24-011796. Sponsor Protocol Number: PAN001-24 BCA. About this study. The primary objective of the study is to evaluate the performance ...